Published in J Allergy Clin Immunol on May 01, 1989
Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax (1991) 1.20
Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses. Thorax (1994) 0.85
Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation. Thorax (1995) 0.77
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46
European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46
Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36
Clinical medicine and research in France. Br Med J (1973) 2.32
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J (2009) 2.29
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Anti-inflammatory effects of macrolide antibiotics. Eur Respir J (1997) 2.04
Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78
Minoxidil in resistant hypertension. Lancet (1977) 1.77
The drug treatment of hypertension. Practitioner (1971) 1.75
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J (2009) 1.70
Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ (2001) 1.68
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68
Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66
Cloning, mapping, and expression of genes involved in the fatty acid-degradative multienzyme complex of Escherichia coli. J Bacteriol (1984) 1.66
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65
Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet (1966) 1.61
Physical training for asthma. Cochrane Database Syst Rev (2005) 1.61
Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 1.58
Editorial: Pharmacokinetics--master or servant? Eur J Clin Pharmacol (1973) 1.57
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52
Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur Respir J (2008) 1.51
Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50
Molecular inroads into the regulation and metabolism of fatty acids, lessons from bacteria. Prog Lipid Res (1999) 1.50
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. Nature (1980) 1.46
Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol (1987) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Surgical treatment of emphysema. Br Med J (1966) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet (1981) 1.42
Hypertension in the young. Q J Med (1967) 1.42
Cerebral mass lesions in patients with AIDS. BMJ (1990) 1.40
Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax (2004) 1.39
An academy of medicine: a future for British postgraduate medicine? Br J Hosp Med (1995) 1.39
Asthma management guidelines. BMJ (1993) 1.39
Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax (2006) 1.38
Metabolism of isoprenaline in dog and man. Br J Pharmacol (1972) 1.38
Effect of raised intraocular pressure on the retinal and choroidal circulation. Invest Ophthalmol (1968) 1.38
Atenolol in essential hypertension. Clin Pharmacol Ther (1976) 1.38
Drug concentration in saliva. Clin Pharmacol Ther (1978) 1.38
Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol (1979) 1.37
Purification and characterization of an outer membrane-bound protein involved in long-chain fatty acid transport in Escherichia coli. J Biol Chem (1987) 1.35
Formation of endothelin by cultured airway epithelial cells. FEBS Lett (1989) 1.34
Metabolism of isoprenaline after aerosol and direct intrabronchial administration in man and dog. Br J Pharmacol (1974) 1.32
Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol (1980) 1.32
The Acyl-CoA synthetases encoded within FAA1 and FAA4 in Saccharomyces cerevisiae function as components of the fatty acid transport system linking import, activation, and intracellular Utilization. J Biol Chem (2001) 1.29
Concentration of (+/-)-propranolol in isolated, perfused lungs of rat. Br J Pharmacol (1976) 1.29
Disruption of the Saccharomyces cerevisiae homologue to the murine fatty acid transport protein impairs uptake and growth on long-chain fatty acids. J Biol Chem (1997) 1.29
Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age. Br J Dermatol (2005) 1.28
Release of prostacyclin in vivo and its role in man. Lancet (1983) 1.27
Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br J Pharmacol (1986) 1.27
Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit. Br J Pharmacol (1973) 1.27
alpha 1-Adrenergic receptors in guinea pig myocardium: identification by binding of a new radioligand, (3H)-prazosin. Biochem Biophys Res Commun (1979) 1.26
Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J (1976) 1.26
Adrenaline and hypertension. Clin Exp Hypertens A (1984) 1.26
Clinical trials of new drugs. J R Coll Physicians Lond (1977) 1.25
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure. BMJ (1988) 1.25
Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet (1976) 1.21
Accuracy of information on medicines in hospital discharge summaries. Intern Med J (2006) 1.21
Methyldopa and haemolytic anaemia. Lancet (1966) 1.21
Physiological and pharmacological interactions of antihypertensive drugs. Proc R Soc Med (1965) 1.20